Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2

被引:48
|
作者
Catusse, J [1 ]
Liotard, A [1 ]
Loillier, B [1 ]
Pruneau, D [1 ]
Paquet, JL [1 ]
机构
[1] Lab Fournier SA, Grp Pharmacochim Recepteurs, F-21121 Daix, France
关键词
G protein-coupled receptor; binding; activation; CXCL8; CXCL1; SB; 225002;
D O I
10.1016/S0006-2952(02)01619-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neutrophil recruitment to inflammatory sites is mediated by two related receptors: CXC chemokine receptors I (CXCR1) and 2 (CXCR2). Both receptors share two ligands, interleukin-8 (CXCL8) and GCP-2 (CXCL6), whereas several chemokines, including growth related oncogen alpha (CXCL 1) and a non-peptide antagonist (SB 225002) are specific for CXCR2. The objective of this study was to map the different amino acids involved in the binding and activation/inhibition of human CXCR2. This was performed by exchanging non-conserved amino acids of CXCR2 with their counterparts in CXCR1. The mutants generated showed that: (a) for CXCL8 binding, the N-terminus of CXCR1 and the second extra-cellular loop of CXCR2 are determinant, the N-terminus of CXCR2 is not sufficient and the transmembrane domain seven is probably involved; (b) for CXCL1, the N-terminus of CXCR2 is necessary but not Sufficient for binding. The activation study indicated that amino acids critical for activation are not necessarily involved in binding process. Finally, the mechanism of binding of a non-peptide antagonist on CXCR2 was investigated: it Occurred through epitopes (a) which were disseminated within the receptor, (b) which differed according to the use of CXCL8 or CXCL1 as a competitor and (c) which did not necessarily overlap with agonist binding sites. We also showed that inhibition of binding and inhibition of activation involved different amino acids. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:813 / 821
页数:9
相关论文
共 34 条
  • [31] MOLECULAR CHARACTERIZATION OF RECEPTORS FOR HUMAN INTERLEUKIN-8, GRO/MELANOMA GROWTH-STIMULATORY ACTIVITY AND NEUTROPHIL ACTIVATING PEPTIDE-2
    CERRETTI, DP
    KOZLOSKY, CJ
    VANDENBOS, T
    NELSON, N
    GEARING, DP
    BECKMANN, MP
    MOLECULAR IMMUNOLOGY, 1993, 30 (04) : 359 - 367
  • [32] Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8(3-74)K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology
    Zhao, Xixing
    Li, Fang
    Town, Jennifer R.
    Zhang, Xiaobei
    Wang, Wenjun
    Gordon, John R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (13) : 1723 - 1731
  • [33] Protection against endotoxin-induced pulmonary pathology (neutrophilic inflammation & lung function) by systemic delivery of the CXCR1/CXCR2 antagonist CXCL8(3-73) K11R/G31P
    Gordon, JR
    Zhang, XB
    Li, F
    Nayyar, A
    FASEB JOURNAL, 2003, 17 (07): : C46 - C46
  • [34] CD40-CD40 ligand interactions in human microglia induce CXCL8 (Interleukin-8) secretion by a mechanism dependent on activation of ERK1/2 and nuclear translocation of nuclear factor-κB (NFκB) and activator protein-1 (AP-1)
    D'Aversa, Teresa G.
    Eugenin, Eliseo A.
    Berman, Joan W.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (03) : 630 - 639